Fundamental dimension Equity attribute | BRBRLeader $9.55▼-1.85% Cap $1.11BP/E 6.7x QuantScore65/100 | AGROPeer $10.12▲+2.95% Cap $5.71BP/E 155.6x QuantScore33/100 | CALMPeer $62.60▼-1.93% Cap $2.92BP/E 52.6x QuantScore45/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
75/100 |
35/100 |
46/100 |
Valuation Multiples, PEG & DCF upside | 100/100 | 21/100 | 60/100 |
Health Piotroski, Altman Z, leverage & liquidity | 63/100 | 28/100 | 93/100 |
Growth Revenue / earnings growth & margins | 27/100 | 25/100 | 0/100 |
Sentiment Analyst ratings, targets & revisions | 62/100 | 53/100 | 26/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 6.7x | 155.6x | 52.6x |
Forward P/E (next FY) | 9.1x | 6.6x | -19.4x |
EV / EBITDA (TTM) | 6.6x | 12.7x | 19.3x |
Price / Sales | 0.5x | 3.5x | 1.2x |
Price / Free Cash Flow | 4.9x | 119.6x | -99.1x |
PEG ratio | -0.34 | -0.12 | -0.55 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 5 / 9 | 6 / 9 |
Altman Z-Score | 4.66 (Safe) | 1.77 (Distress) | 6.67 (Safe) |
Total debt / equity | -2.43 | 1.34 | 0.00 |
Quick ratio | 0.9x | 0.9x | 5.6x |
Interest coverage | 3.9x | 1.1x | 69.9x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +16.1% | -6.0% | -31.7% |
Net income growth YoY | -12.3% | -109.0% | -74.0% |
Gross margin (TTM) | 28.6% | 30.0% | 14.3% |
Operating margin (FY) | 15.4% | 4.7% | 12.0% |
FCF margin (FY) | 11.0% | 1.4% | 11.4% |
5. Trailing price performancePrice change over period |
1M return | +24.2% | -4.8% | -8.6% |
3M return | -26.3% | -4.3% | -30.7% |
6M return | -41.0% | -20.8% | -17.9% |
Year to date | -64.3% | +27.6% | -21.3% |
1Y return | -71.1% | +29.6% | -30.5% |
3Y return | -78.5% | -7.4% | +38.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $114.45 +1098.4% upside | $4.07 -59.8% premium | $135.46 +116.4% upside |
Wall Street consensus target | $12.21 +27.9% · range $9.50–$15.00 | $14.00 +38.3% · range $13.20–$14.80 | $81.00 +29.4% · range $60.00–$100.00 |
Consensus stance | 67% Buy33% Hold0% Sell | 38% Buy50% Hold13% Sell | 11% Buy67% Hold22% Sell |